The study of adverse drug reactions of antihypertensive medicines in essential hypertension patients in Hi-Tech Medical College and Hospital, Bhubaneswar, Odisha, India

Bikash Roy; Srikanta Mohanty; Anju Prasad; Chaitali Pattanayak; Ratna Palit; Ashok Singh Chouhan

doi:10.18203/2319-2003.ijbcp20191570

Authors

Bikash Roy Department of Pharmacology, Hi-Tech Medical College and Hospital (HMC & H), Bhubaneswar (BBSR), Odisha, India
Srikanta Mohanty Department of Pharmacology, Hi-Tech Medical College and Hospital (HMC & H), Bhubaneswar (BBSR), Odisha, India
Anju Prasad Department of Pharmacology, Hi-Tech Medical College and Hospital (HMC & H), Bhubaneswar (BBSR), Odisha, India
Chaitali Pattanayak Department of Pharmacology, Hi-Tech Medical College and Hospital (HMC & H), Bhubaneswar (BBSR), Odisha, India
Ratna Palit Department of Pharmacology, Hi-Tech Medical College and Hospital (HMC & H), Bhubaneswar (BBSR), Odisha, India
Ashok Singh Chouhan Department of Pharmacology, Hi-Tech Medical College and Hospital (HMC & H), Bhubaneswar (BBSR), Odisha, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20191570

Keywords:

Adverse drug reaction, Causality assessment, Essential hypertension

Abstract

Background: Every drug has the potentiality to cause an adverse drug reaction (ADR). ADRs are a major problem in drug therapy .The aim of this study was to assess the incidence and causality of ADRs to antihypertensive agents used for the essential hypertensive patients attending at the general medicine out patients departments of Hi-Tech Medical College and Hospital, Bhubaneswar Odisha, during the time period of November 2016 to October 2018.

Methods: This prospective-observational study was carried out in general medicine outpatient department of Hi-Tech Medical College and Hospital, Bhubaneswar, Odisha.

Results: Out of 254 patients, 78 (30.71%) patients were developed ADRs to antihypertensive drugs. 51 (65.38%) were female and 27 (34.62%) were male. Calcium channel blockers were the commonest therapeutic class of antihypertensive drugs associated with ADRs (n = 50, 64.10%). According to WHO causality assessment scale most of the ADRs were “probable” 41 (52.56%), followed by “possible” 21 (26.92%), unclassifiable 13 (16.67%) and unlikely 3 (3.85%).

Conclusions: The results of this study concluded that antihypertensive drugs able to induce the development of adverse drug reactions, which were significant cause of increase burden on health care system and decrease the quality of life, the health care professionals should take care about the rational use of antihypertensive agents. Thus, to minimize the incidence of adverse drug reaction and to increase the quality of life.

Metrics

Metrics Loading ...

References

The Safety of medicines in public health programmes. Pharmacovigilance an essential tool. Geneva WHO. 2006. Available at: https://www.who.int/medicines/areas/quality_safety/safety_efficacy/Pharmacovigilance_B.pdf. Accessed 10 January 2019.

Vora MB, Trivedi HR, Shah BK, Tripathi CB. Adverse drug reactions in inpatients of internal medicine wards at a tertiary care hospital: A prospective cohort study. J Pharmacol Pharmacotherapeut. 2011;2(1):21-5.

Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200-5.

Alomar MJ. Factors affecting the development of adverse drug reactions. Saudi Pharmaceut J. 2014;22(2):83-94.

Beijer HJ, De Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharmacy World Sci. 2002;24(2):46-54.

Jose J, Rao PG. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Pharmacol Res. 2006;54(3):226-33.

Kennedy DL, Goldman SA, Lillie RB. Spontaneous reporting in the United States. In: Strom BL, editor. Pharmacoepidemiology. 3rd ed. Chichester: John Wiley and Sons, Ltd.; 2000:151-174.

de Araújo Lobo MG, Pinheiro SM, Castro JG, Momenté VG, Pranchevicius MC. Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil. BMC Pharmacol Toxicol. 2013 Dec;14(1):5.

Patidar D, Rajput MS, Nirmal NP, Savitri W. Implementation and evaluation of adverse drug reaction monitoring system in a tertiary care teaching hospital in Mumbai, India. Interdisciplinary Toxicol. 2013 Mar 1;6(1):41-6.

Shrivastava M, Uchit G, Chakravarti A, Joshi G, Mahatme M, Chaudhari H. Adverse drug reactions reported in Indira Gandhi government medical college and hospital, Nagpur. J Assoc Physicians India. 2011;59:296-9.

Uppsala Monitoring Centre. The use of the World Health Organization-Uppsala Monitoring Centre (WHO-UMC) system for standardised case causality assessment. 2006. Available at: http://who-umc.org/graphics/4409.pdf.

Busto U, Naranjo CA, Sellers EM. Comparison of two recently published algorithms for assessing the probability of adverse drug reactions. Br J Clin Pharm. 1982;13: 223-7.

Svartberg J, von Muhlen D, Schirmer H, Barrett-Connor E, Sundfjord J, et al. Association of endogenous testosterone with blood pressure and left ventricular mass in men. The Tromso Study. Eur J Endocrinol. 2004;150(1):65-71.

Reckelhoff JF. Gender differences in the regulation of blood pressure. Hypertension. 2001;37(5):1199-208.

Jainaf Nachiya RA, Parimalakrishnan S, Ramakrishna Rao M. Study on drug utilization pattern of antihypertensive medications on out-patients and inpatients in a tertiary care teaching hospital: A cross sectional Study. Afr J Pharmacy Pharmacol. 2015;9(11):383-96.

Brown MJ. Renin: friend or foe?. Heart. 2007;93(9):1026-33.

Tiwari R, Bhardwaj A, Alam N, Dabas V, Sharma S. To evaluate the drug utilization pattern in patients using antihypertensive drug therapy. Asian J Biochem Pharm Res. 2012;2(1):425-33.

Pai PG, Shenoy J, Sanji N. Prescribing patterns of antihypertensive drugs in a South Indian tertiary care hospital. Drug Invention Today. 2011;3(4):38-40.

Etuk E, Isezuo SA, Chika A, Akuche J, Ali M. Prescription pattern of anti-hypertensive drugs in a tertiary health institution in Nigeria. Ann Afr Med. 2008;7(3):128-32.

Maduram A, Harikrishna - Prescription pattern of antihypertensive drugs in Shri Sathya Sai medical college & research institute. Int J Basic Med Sci. 2013;4(2):68-72.

John LJ, Devi P, Guido S. Utilization of antihypertensive medications among the critically ill patients. RJPBCS. 2012;3(3):650-4.

Goodman & Gilman’s - The Pharmacological Basis of Therapeutics by- Laurence L. Brunton, RandaHilal-Dandan, Bjorn C. Knollmann- McGraw Hill Education, 13th ed.; 2017:489-526.

Solanki KC, Mistry RA, Singh AP, Jadav SP, Patel NM, Trivedi HR. Drug utilization study of antihypertensive drugs and their adverse effects in patients of a tertiary care hospital. J Clin Exp Res. 2013;1(3):58-67.

Hussain A, Aqil M, Alam MS, Khan MR, Kapur P, Pillai KK. A pharmacovigilance study of antihypertensive medicines at a South Delhi hospital. Indian J Pharm Sci. 2009;71(3):338-41.

Basak SC, Ravi K, Manavalan R, Sahoo K. A study of adverse drug reaction to antihypertensive drugs perceived by patients in a rural hospital. Indian J Pharm Sci. 2004;66(6):814-17.

Alomar MJ, Strauch CC. A prospective evaluation of antihypertensive medications safety and efficacy in United Arab Emirates private hospitals. Am J Pharmacol Toxicol. 2010;5(2):89-94.

Rende P, Paletta L, Gallelli G, Raffaele G, Natale V, Brissa N, et al. Retrospective evaluation of adverse drug reactions induced by antihypertensive treatment. J Pharmacol Pharmacother. 2013;4(1):S47-50.